[go: up one dir, main page]

MX2007011264A - Composiciones nutricionales para modular la biodisponibilidad de vitamina c. - Google Patents

Composiciones nutricionales para modular la biodisponibilidad de vitamina c.

Info

Publication number
MX2007011264A
MX2007011264A MX2007011264A MX2007011264A MX2007011264A MX 2007011264 A MX2007011264 A MX 2007011264A MX 2007011264 A MX2007011264 A MX 2007011264A MX 2007011264 A MX2007011264 A MX 2007011264A MX 2007011264 A MX2007011264 A MX 2007011264A
Authority
MX
Mexico
Prior art keywords
bio
availability
vitamin
nutritional compositions
modulating
Prior art date
Application number
MX2007011264A
Other languages
English (en)
Inventor
Myriam Richelle
Gary Williamson
Heike Steiling
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2007011264A publication Critical patent/MX2007011264A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)

Abstract

La presente invencion se relaciona con composiciones capaces de modular la biodisponibilidad de vitamina C en individuos. En particular, la presente invencion se relaciona con metodos para identificar compuestos capaces de modular la expresion de transportadores de vitamina C, el uso de dichos compuestos en alimentos o productos alimenticios y el uso de los mismos para el tratamiento o prevencion de tejido enfermo o estresado.
MX2007011264A 2005-03-15 2006-03-15 Composiciones nutricionales para modular la biodisponibilidad de vitamina c. MX2007011264A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05005569 2005-03-15
PCT/EP2006/002370 WO2006097288A1 (en) 2005-03-15 2006-03-15 Nutritional compositions for modulating vitamin c bio-availability

Publications (1)

Publication Number Publication Date
MX2007011264A true MX2007011264A (es) 2008-03-12

Family

ID=35045357

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007011264A MX2007011264A (es) 2005-03-15 2006-03-15 Composiciones nutricionales para modular la biodisponibilidad de vitamina c.

Country Status (11)

Country Link
US (1) US20080193505A1 (es)
EP (2) EP1869458A1 (es)
JP (1) JP2008533078A (es)
KR (1) KR20070116631A (es)
CN (1) CN101175995A (es)
AU (1) AU2006224792A1 (es)
BR (1) BRPI0608511A2 (es)
CA (1) CA2601974A1 (es)
MX (1) MX2007011264A (es)
RU (1) RU2007137828A (es)
WO (1) WO2006097288A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0811992D0 (en) * 2008-07-01 2008-08-06 Mithen Richard Treatment
US8937050B2 (en) * 2011-10-31 2015-01-20 The Johns Hopkins University Methods and compositions for treatment of autism
US20160066608A1 (en) * 2014-09-04 2016-03-10 Jeffery M. Meyer Potato salad mix
JP6382667B2 (ja) * 2014-09-26 2018-08-29 株式会社ファンケル Ｌ−アスコルビン酸徐放性製剤
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JP2018138525A (ja) * 2017-02-24 2018-09-06 株式会社ディーエイチシー ビタミンｃトランスポーター産生促進剤及びビタミンｃ吸収促進用組成物
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
CN108893531A (zh) * 2018-06-12 2018-11-27 广州中安基因科技有限公司 一种儿童维生素需求基因检测试剂盒
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0806207A4 (en) * 1995-01-18 2002-01-02 Taisho Pharmaceutical Co Ltd MEDICINE FOR EKZEEM
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
JPH11222412A (ja) * 1997-12-01 1999-08-17 Shiseido Co Ltd 皮膚外用剤
US6066327A (en) * 1997-12-17 2000-05-23 Color Access, Inc. Antioxidant mixture
US20020106415A1 (en) * 1999-02-22 2002-08-08 Norikazu Iwase Interleukin-4production inhibitors
US7371536B2 (en) * 1999-11-08 2008-05-13 Hediger Matthias A Methods for transporting vitamin C
US6403654B1 (en) * 2000-04-13 2002-06-11 Mariana De Oliveira Compositions for and method of treatment for psoriasis
JP2002249771A (ja) * 2001-02-22 2002-09-06 Mitsubishi Chemicals Corp 酸化防止剤
JP2003192564A (ja) * 2001-12-27 2003-07-09 Nagase & Co Ltd メラニン生成抑制剤
JP2004359630A (ja) * 2003-06-06 2004-12-24 Yamanouchi Pharmaceut Co Ltd ジフルオロジフェニルメタン誘導体及びその塩

Also Published As

Publication number Publication date
US20080193505A1 (en) 2008-08-14
WO2006097288A9 (en) 2007-11-01
EP2060914A2 (en) 2009-05-20
JP2008533078A (ja) 2008-08-21
EP1869458A1 (en) 2007-12-26
CA2601974A1 (en) 2006-09-21
EP2060914A3 (en) 2010-04-07
AU2006224792A1 (en) 2006-09-21
RU2007137828A (ru) 2009-04-20
KR20070116631A (ko) 2007-12-10
WO2006097288A1 (en) 2006-09-21
CN101175995A (zh) 2008-05-07
BRPI0608511A2 (pt) 2010-01-05

Similar Documents

Publication Publication Date Title
EP2248430A3 (en) A food containing a probiotic and an isolated beta-glucan and methods of use thereof
MX2007008021A (es) Composiciones que incluyen hierro.
MY147247A (en) Organic compounds and their uses
WO2008097541A3 (en) Variants derived from actriib and uses therefor
MY155710A (en) Composition for regulating lipid metabolism
MX336723B (es) Combinacion de (a) un inhibidor de fosfoinositido 3-cinasa y (b) un modulador de la ruta de ras/raf/mek.
WO2009044173A3 (en) Methods of treating cancer using notch pathway inhibitors
EP2532657A3 (en) Compounds and methods of use
PH12012502314A1 (en) Tube feed packages and methods for using same
BRPI0818079A8 (pt) Composição de lipídeo
WO2008079030A8 (en) Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
AU316078S (en) Surgical tissue stimulator/locator
EP4424368A3 (en) Compositions comprising an urolithin compound
MX2009006342A (es) Composicion de complemento alimenticio para tratamiento de enfermedades oculares.
WO2006112716A3 (en) Nutritional supplement for hiv patients
MXPA02011476A (es) Fuente de triptofano de plantas y usos para el mismo.
MY148723A (en) Use of pinolenic acid for the treatment of obesity
SI1904029T2 (sl) Oralni, hitro razpadajoäśi film, ki se ne da izpljuniti, vsebujoäś olanzapin
EP1872668A4 (en) NUTRITIVE COMPOSITION
MX2007011264A (es) Composiciones nutricionales para modular la biodisponibilidad de vitamina c.
PH12013500761A1 (en) Cysteine and food intake
RU2009134848A (ru) Транквилизатор и функциональный продукт питания
AU2011343331A8 (en) Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
BRPI0516137A (pt) composição de bebida para cuidados com a pele
WO2009037398A3 (fr) Composition aiimentaire pour ameliorer la digestibilite des lipides alimentaires

Legal Events

Date Code Title Description
FA Abandonment or withdrawal